Department of Immunology and Microbiology, School of Life Sciences, Southern University of Science and Technology, Shenzhen, Guangdong, 518055, China.
Department of Microbiology, Harvard Medical School, Boston, MA, 02115, USA.
Nat Commun. 2022 Jul 25;13(1):4277. doi: 10.1038/s41467-022-32055-z.
TREX1 is a cytosolic DNA nuclease essential for regulation of cGAS-STING immune signaling. Existing structures of mouse TREX1 establish a mechanism of DNA degradation and provide a key model to explain autoimmune disease, but these structures incompletely explain human disease-associated mutations and have limited ability to guide development of small-molecule therapeutics. Here we determine crystal structures of human TREX1 in apo and DNA-bound conformations that provide high-resolution detail of all human-specific features. A 1.25 Å structure of human TREX1 establishes a complete model of solvation of the exonuclease active site and a 2.2 Å structure of the human TREX1-DNA complex enables identification of specific substitutions involved in DNA recognition. We map each TREX1 mutation associated with autoimmune disease and establish distinct categories of substitutions predicted to impact enzymatic function, protein stability, and interaction with cGAS-DNA liquid droplets. Our results explain how human-specific substitutions regulate TREX1 function and provide a foundation for structure-guided design of TREX1 therapeutics.
TREX1 是一种细胞质 DNA 核酸内切酶,对于 cGAS-STING 免疫信号的调节至关重要。现有的小鼠 TREX1 结构确立了 DNA 降解的机制,并提供了一个关键模型来解释自身免疫性疾病,但这些结构并不能完全解释与人类疾病相关的突变,并且对小分子治疗药物的开发的指导作用有限。在这里,我们确定了apo 和 DNA 结合构象下的人 TREX1 晶体结构,这些结构提供了所有人类特异性特征的高分辨率细节。人 TREX1 的 1.25 Å 结构建立了外切核酸酶活性位点的完全溶剂化模型,而人 TREX1-DNA 复合物的 2.2 Å 结构则能够识别参与 DNA 识别的特定取代。我们对与自身免疫性疾病相关的每个 TREX1 突变进行了映射,并确定了影响酶功能、蛋白质稳定性以及与 cGAS-DNA 液滴相互作用的特定取代的不同类别。我们的研究结果解释了人类特异性取代如何调节 TREX1 的功能,并为基于结构的 TREX1 治疗药物设计提供了基础。